Dirks JH, Robinson S, Burdmann E, Correa-Rotter R, Mezzano S, Rodriguez-Iturbe B. Prevention strategies for chronic kidney disease in Latin America: a strategy for the next decade - a report on the Villarica Conference. Ren Fail 2006; 28: 611-615....
(smoking status, BP, cholesterol, other non-Framingham risk factors—BMI, chronic kidney disease (CKD) screening with urinary Albumin to Creatinine ratio, ... David,Peiris,Tim,... - 《Bmj Open》 被引量: 35发表: 2012年 Differential Effects of Strong and Regular Statins on the Clinical Outcom...
Novel Nonsteroidal Mineralocorticoid Receptor Antagonists a Promising Strategy for Chronic Kidney Disease Patients and Diabetic Nephropathy BANTAO JournalRroji, MeritaBarbullushi, Myftar
Primary Sjögren syndrome (pSS) is a common chronic autoimmune disease characterized by highly lymphocytic infiltration of exocrine glands, especially salivary glands and lacrimal glands, which often results in dry eyes, dry mouth, and fatigue [1]. Moreover, it can cause damage to extra-glandular...
Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by lig...
As a result, injury results in progressive decline in renal function, ultimately leading to end stage renal disease (ESRD) such that kidney transplantation or dialysis is required. Increasing prevalence of ESRD has created a high demand for new regenerative technologies to compensate for disrupted ...
chronic kidney disease (CKD), and obesity [1].As for HF, the global diabetes prevalence keeps increasing, with a current estimate of 9.3%, and is expected to rise further to 10.2% by 2030, as well as its financial burden [2,3]. In 2021, there were 529 million people living with dia...
Autophagy, the intracellular lysosomal degradation process plays a pivotal role in podocyte homeostasis in diabetic kidney disease (DKD). Lysosomal function, autophagic activity, and their actions were investigated in vitro and in vivo. We found that LC3
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680. doi:10.1136/bmj.f5680 PubMedGoogle ScholarCrossref 22. Silverman MG, Ference BA, Im K, et al. ...
Musi says he and Kirkland and their collaborators have begun a trial in 15 more lung patients, and the team at Mayo is testing the drug combination in 20 patients with chronic kidney disease. “If we see effectiveness signals and don’t encounter really bad side effects, we’ll ...